Tolga Tanguler
Corporate Officer/Principal chez ALNYLAM PHARMACEUTICALS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Tolga Tanguler is currently the Chief Commercial Officer at Alnylam Pharmaceuticals, Inc. He previously worked as a Director at Ferrosan Holding A, Regional President-North America at Pfizer Inc., and Senior Vice President at Alexion Pharmaceuticals, Inc. He holds an MBA from Michigan State University and an undergraduate degree from Istanbul University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 9 987 ( 0,01% ) | 1 M $ | 31/03/2024 |
Postes actifs de Tolga Tanguler
| Sociétés | Poste | Début |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/01/2021 |
Anciens postes connus de Tolga Tanguler
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ferrosan Holding A/S
 Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Director/Board Member | - |
Formation de Tolga Tanguler
| Michigan State University | Masters Business Admin |
| Istanbul University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Retail Trade |
